Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHarvard Bioscience Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.63 | -$0.61 | -$0.62 |
| Q2 2026 | 1 | -$0.43 | -$0.42 | -$0.43 |
| Q3 2026 | 1 | -$0.37 | -$0.36 | -$0.37 |
| Q4 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
Harvard Bioscience Inc. Earnings Date And Information
Harvard Bioscience Inc. last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-0.33 earnings per share for the quarter, topping analysts' consensus estimates of $-0.62 by $0.29. The company had revenue of 20.76 M for the quarter and had revenue of 86.55 M for the year. Harvard Bioscience Inc. has generated $-13 earnings per share over the last year ($-12.8 diluted earnings per share) and currently has a price-to-earnings ratio of -2.54. Harvard Bioscience Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Harvard Bioscience Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | -$0.62 | -$0.77 | -0.15 | $21.20 M | $20.76 M |
| 03/13/2026 | Q4 2025 | N/A | -$0.64 | N/A | $23.10 M | $23.74 M |
| 11/06/2025 | Q3 2025 | $0.01 | -$0.28 | -0.28 | $20.00 M | $20.59 M |
| 08/11/2025 | Q2 2025 | -$0.03 | -$0.52 | -0.49 | $18.75 M | $20.45 M |
| 05/12/2025 | Q1 2025 | -$0.04 | -$11.40 | -11.36 | $19.20 M | $21.77 M |
| 03/13/2025 | Q4 2024 | N/A | $0.00 | N/A | $24.15 M | $24.56 M |
| 11/08/2024 | Q3 2024 | N/A | -$1.10 | N/A | $23.70 M | $21.97 M |
| 08/08/2024 | Q2 2024 | $0.05 | -$0.67 | -0.72 | $26.40 M | $23.10 M |
| 05/07/2024 | Q1 2024 | $0.02 | -$1.10 | -1.12 | $25.80 M | $24.51 M |
| 03/07/2024 | Q4 2023 | $0.05 | -$0.43 | -0.48 | N/A | $28.15 M |
| 11/07/2023 | Q3 2023 | $0.04 | -$0.29 | -0.33 | N/A | $25.36 M |
| 08/08/2023 | Q2 2023 | $0.06 | -$0.23 | -0.29 | N/A | $28.76 M |
| 04/26/2023 | Q1 2023 | N/A | $0.15 | N/A | N/A | $29.98 M |
| 03/09/2023 | Q4 2022 | $0.03 | -$0.40 | -0.43 | N/A | $28.43 M |
| 11/08/2022 | Q3 2022 | N/A | -$0.82 | N/A | N/A | $26.92 M |
| 08/04/2022 | Q2 2022 | N/A | $0.59 | N/A | N/A | $29.21 M |
| 05/04/2022 | Q1 2022 | $0.05 | -$1.70 | -1.75 | N/A | $28.78 M |
| 03/11/2022 | Q4 2021 | N/A | $0.20 | N/A | N/A | $33.06 M |
| 11/05/2021 | Q3 2021 | N/A | -$0.04 | N/A | N/A | $29.66 M |
| 08/06/2021 | Q2 2021 | N/A | -$0.10 | N/A | N/A | $29.20 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Harvard Bioscience Inc. Earnings: FAQ's
In the previous quarter, Harvard Bioscience Inc. (:HBIO) reported $-0.33 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.62 by $0.29.
The conference call for Harvard Bioscience Inc.'s latest earnings report can be listened to online.
The conference call transcript for Harvard Bioscience Inc.'s latest earnings report can be read online.
Harvard Bioscience Inc. (:HBIO) has a recorded annual revenue of $86.55 M.
Harvard Bioscience Inc. (:HBIO) has a recorded net income of $-56,700,000.Harvard Bioscience Inc. has generated $-12.8 earnings per share over the last four quarters.
Harvard Bioscience Inc. (:HBIO) has a price-to-earnings ratio of -2.54 and price/earnings-to-growth ratio is -0.03.